Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pairs) from January 2011 to March 2023, documenting the transition between these surgical techniques, with a noted crossover in 2018.
Background: Liver transplantation is a primary treatment for end-stage liver disease, enhancing survival rates and life quality. Living donor liver transplantation (LDLT) has gained prominence due to the scarcity of deceased donor organs. Historically, the open technique dominated living donor hepatectomies. However, advances in minimally invasive surgery (MIS) led to laparoscopic and later robotic procedures. With the introduction of robotic surgery, MIS for complex surgeries improved, offering better precision and ergonomics.
Objective: To compare the short and long-term outcomes of open, laparoscopic, and robotic LDLT, focusing on both donors and recipients.
Methods: Study Design: Retrospective analysis of data from a prospective liver transplant registry, examining three LDLT techniques.
Setting: King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Participants: All consecutive living donor and recipient pairs undergoing LDLT between January 2011 and March 2023. Exclusions include dual or domino LDLT.
Surgical Techniques: Open, laparoscopic, and robotic techniques used for donor hepatectomies.
Variables: Primary focus on morbidity, conversion rates, and in-hospital mortality for both donors and recipients. Secondary variables will include major complications, graft, and recipient survival rates.
Data Sources and Measurement: Data sourced from a secured, encrypted transplant database, detailing patient data, operation characteristics, and post-op outcomes. Complication severity will be captured using the Clavien-Dindo classification and Comprehensive Complication Index™.
Study Size: Determined by the total number of procedures during the study duration, deemed sufficient for comparison.
Quantitative Variables: Demographics, comorbidities, operational details, post-op and long-term outcomes.
Statistical Methods: Various statistical tests will be employed for comparison, including the Student t, Mann-Whitney U, one-way ANOVA, Fischer and Chi square. Survival will be evaluated using the Kaplan-Meier method. Multivariable binary logistic regression will be employed. All statistical analyses will be conducted using R.
Ethics Approval: Obtained (ID: RAC 2121012) and in accordance with the 1964 Helsinki declaration.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Open | Open donor hepatectomy approach: a portion of the liver is resected from a living donor using the traditional open surgical technique, involving a large incision to access the liver directly. This method is most commonly used in living donor liver transplantation nowadays. |
| |
| Laparoscopic | Laparoscopic donor hepatectomy is a minimally invasive surgical approach where a portion of the liver is resected from a living donor using small incisions and specialized instruments. |
| |
| Robotic | Robotic donor hepatectomy is an advanced, minimally invasive surgical technique where a portion of the liver is resected from a living donor using robotic instruments. This method is known to provide enhanced precision, improved ergonomics, and superior 3D visualization. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Donor hepatectomy | Procedure | Donor hepatectomy is a surgical procedure to resect a portion of the liver from a living donor for transplantation. This usually involved the right lobe, the left lobe or the left lateral section of the liver. Depending on the surgical method, this can be achieved through open, laparoscopic, or robotic-assisted techniques. As for the recipient, liver transplantation involves a total hepatectomy of the diseased liver from the recipient and implantation of the liver graft from the donor. This is typically performed using the open surgical approach. |
| Measure | Description | Time Frame |
|---|---|---|
| Donor overall morbidity rate | Complication rate of any severity according to the Clavien-Dindo Classification | From date of donor hepatectomy until the date of first hospital discharge assessed up to 90 days postoperatively. |
| Recipient overall morbidity rate | Complication rate of any severity according to the Clavien-Dindo Classification | From date of liver transplantation until the date of hospital discharge assessed up to 90 days postoperatively. |
| Recipient in-hospital mortality rate | Recipient death up to 90 days of follow up | From date of liver transplantation until the date of death assessed up to 90 days post-transplant. |
| Measure | Description | Time Frame |
|---|---|---|
| Donor minimally invasive surgery conversion to open rate | Includes conversion to open surgery for both laparoscopic and robotic approaches. This does not apply for the open surgical approach. | Time from operation start until conversion to open in minutes assessed up to 720 min |
| Donor hospital stay in days |
| Measure | Description | Time Frame |
|---|---|---|
| Major morbidity rates | These include complications of Grade > 2 according to the Clavien-Dindo Classification, i.e., requiring an intervention on the patient requiring organ support in the Intensive Care Unit | From date of operation until the date of hospital discharge assessed up to 90 days postoperatively. |
| Specific complication rates |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study cohort consists of 1,724 living donor and recipient pairs, amounting to a total of 3,448 individuals. These donors and recipients participated in living donor liver transplantation (LDLT) procedures at the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia.
The donors provided a portion of their liver for transplantation. The recipient group is diverse, including both adult and pediatric patients receiving transplants from adult donors. Both laparoscopic-assisted and robotic-assisted transplant procedures will be part of the study to ensure an intention-to-treat analysis.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dieter C Broering, MD, PhD | Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre | Riyadh | 11563 | Saudi Arabia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058625 | End Stage Liver Disease |
| D017114 | Liver Failure, Acute |
| D065290 | Acute-On-Chronic Liver Failure |
| D006528 | Carcinoma, Hepatocellular |
| ID | Term |
|---|---|
| D017093 | Liver Failure |
| D048550 | Hepatic Insufficiency |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
Number of days the donor was hospitalised during first hospitalisation. Does not include re-hospitalizations. |
| From date of donor hepatectomy until the date of first hospital discharge assessed up to 90 days postoperatively. |
| Recipient Intensive Care Unit (ICU) stay in days | Total number of days recipient stayed in ICU. This included readmissions to ICU. | Total number of days hospitalised in ICU, from date of liver transplant until the date of discharge from ICU assessed up to 90 days postoperatively. |
| Recipient hospital stay in days | Number of days the recipient was hospitalised. Does not include rehospitalizations. | From date of liver transplant until the date of first hospital discharge assessed up to 90 days postoperatively. |
| Graft survival rates | Graft survival defined as re-transplantation or recipient death. | From date of liver transplantation until the date of re-transplantation or recipient death or last follow up assessed up to 120 months post-transplant |
| Recipient survival rates | Recipient survival defined as death post-transplant | From date of liver transplantation until the date of recipient death or last follow up assessed up to 120 months post-transplant |
Infection, bleeding, ascites, vascular, and biliary complications |
| From date of operation until the date of hospital discharge assessed up to 90 days postoperatively. |
| D000230 |
| Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008113 | Liver Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |